REZOLUTE, INC. Operating Leases, Future Minimum Payments, Due in Four Years
REZOLUTE, INC. (RZLT) had Operating Leases, Future Minimum Payments, Due in Four Years of $233.58 thousand as of 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2019-05-10
- 2019-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $233.58K.
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $148.64K.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Four Years $347.84K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $347.84K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2019-03-31 | $233.58K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $148.64K 10-Q · filed 2019-02-14 |
| 2018-09-30 | $347.84K 10-Q · filed 2018-12-14 |
| 2018-06-30 | $347.84K 10-K · filed 2018-10-15 |
| 2018-03-31 | $338.39K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $338.39K 10-Q · filed 2018-02-14 |
| 2017-09-30 | $338.39K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $338.39K 10-K · filed 2017-09-22 |
| 2017-03-31 | $516.14K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $335.75K 10-Q · filed 2017-02-02 |
| 2016-09-30 | $335.75K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $335.75K 10-K · filed 2016-09-28 |
| 2016-03-31 | $392.86K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $392.86K 10-Q · filed 2016-02-16 |
| 2015-09-30 | $392.86K 10-Q · filed 2015-11-16 |
| 2015-06-30 | $392.86K 10-K · filed 2015-09-28 |
| 2015-03-31 | $381.36K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $381.36K 10-Q · filed 2015-02-17 |
| 2014-09-30 | $381.36K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $381.36K 10-K · filed 2014-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |